Novasep Opens New Office in Thailand
News Dec 27, 2014
Novasep has announced that it is expanding its presence in South East Asia with the opening of an office in Bangkok, Thailand.
The addition of this new office follows Novasep’s expansion into India last December, with the opening of its subsidiary in Bangalore. Prior to that, Novasep set up its Asia Process Development and Engineering Center in Shanghai, China, in 2012.
This further move into South East Asia is another significant step forward for Novasep, which aims to meet increasing demand for high efficiency processes in the food and feed industries, particularly in Thailand, Cambodia, Laos, Indonesia and the Philippines. These countries are among the fastest growing economies in the ASEAN-10 countries according to OECD (Organization for Economic Cooperation and Development).
“We have equipped this new office with local capabilities, together with local sourcing and project management, for on-site process development,” said Damien Brichant, Asia Pacific manager. “Novasep can now offer more proximity and a premium quality service to our customers in the region.”
“The sound technical expertise and comprehensive market knowledge of our Thai team perfectly complement our first-class competitive offering from single purification units to complete ingredient production plants,” said Nadège Laborde, president of Industrial Biotech BU. “Novasep has a strong and long-term presence in Asia. Our establishment in Thailand is a new step in our strategy to better serve our clients.”
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Cocaine Use Alters Gene Expression in Brain Reward CircuitsNews
A study in Biological Psychiatry investigates transcriptome-wide alterations in response to cocaine self-administration in mice.
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development PartnershipNews
MD Anderson will progress the drug candidate through Phase I clinical development with Ipsen being responsible for further global development and commercialization.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018